Fox Chase Cancer Center News

PHILADELPHIA (August 9, 2023) — Sanjay S. Reddy, MD, FACS, an Associate Professor in the Department of Surgical Oncology at Fox Chase Cancer Center, has received an Investigator Initiated Clinical Trial grant from Fox Chase’s Office of Sponsored Research to study the impact of diet and lifestyle factors on pancreatic ductal adenocarcinoma, or PDAC, the most common form of pancreatic cancer.

PHILADELPHIA (August 8, 2023) — Fox Chase Cancer Center is pleased to announce the hiring of Michael G. Tecce, DO, as an Assistant Professor in the Division of Plastic and Reconstructive Surgery in the Department of Surgical Oncology.

PHILADELPHIA (August 8, 2023) — A new study led by Igor Astsaturov, MD, PhD, Co-Director of the Marvin & Concetta Greenberg Pancreatic Cancer Institute at Fox Chase Cancer Center, demonstrates two key components necessary for a new drug candidate, LP-184, to effectively treat pancreatic adenocarcinoma. The findings were published today in Molecular Cancer Therapeutics, a journal of the American Association for Cancer Research.

PHILADELPHIA (August 7, 2023)—Fox Chase Cancer Center is pleased to announce the hiring of Yu “Sunny” Liu, PhD, as an assistant professor in the Nuclear Dynamics and Cancer research program and the Cancer Epigenetics Institute (CEI).

PHILADELPHIA (July 27, 2023) — Andrea Porpiglia, MD, MSc, FACS, an Associate Professor in the Department of Surgical Oncology at Fox Chase Cancer Center, has been promoted to Assistant Program Director for the Complex General Surgical Oncology Fellowship.

PHILADELPHIA (July 27, 2023)—Temple Health and Fox Chase Cancer Center are pleased to announce the hiring of Sukhmani K. Padda, MD, as Professor and Vice Chair of Medical Oncology at the Fox Chase Cancer Center at Temple University Hospital.

PHILADELPHIA (July 24, 2023) — Previous research has shown that blocking the ability of leukemia cells to repair self-inflicted genetic damage can cause them to die off on their own. But while this approach is effective in the short term, the cancer eventually comes back.

PHILADELPHIA (July 24, 2023) — Researchers at Fox Chase Cancer Center have made a new discovery about the transcription factor ThPOK that may be useful in the treatment of sepsis, other types of pathogen invasion, and ultimately, cancer.